Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025
Title: Minqing Tian: Innovator in Pharmaceutical Composition
Introduction
Minqing Tian is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of resistant hypertension. His innovative approach combines various compounds to enhance therapeutic efficacy.
Latest Patents
Minqing Tian holds a patent for a pharmaceutical composition that includes amlodipine, chlorthalidone, and amiloride. This composition is specifically designed for treating resistant hypertension. The patent outlines its application in addressing low renin/low aldosterone resistant hypertension and targeting organ damage in patients suffering from this condition. He has 1 patent to his name.
Career Highlights
Throughout his career, Minqing Tian has worked with prominent companies in the pharmaceutical industry, including Shenzhen Ausa Pharmed Co., Ltd. and Shenzhen Ausa Pharmaceutical Co., Ltd. His work has focused on developing effective treatments that address complex health issues.
Collaborations
Minqing Tian has collaborated with several professionals in his field, including Guangliang Chen and Duo Yu. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Minqing Tian's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare outcomes for patients with resistant hypertension. His work continues to influence the field and offers hope for better treatment options.